Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Rhabdoid Tumor × Craniospinal Irradiation × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Medulloblastoma 2 Brain Neoplasms 2 Teratoma 1 Rhabdoid Tumor 1 Neuroectodermal Tumors, Primitive 1 Meningeal Carcinomatosis 1 Lung Neoplasms 1 Intracranial Germ Cell Tumors 1 Infratentorial Neoplasms 1 Glioma 1 Ependymoma 1 Central Nervous System Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 14 Etoposide 10 Magnetic Resonance Spectroscopy 8 Carboplatin 8 X-Rays 7 Phantoms, Imaging 7 Granulocyte Colony-Stimulating Factor 7 etoposide phosphate 6 Thiotepa 6 Temozolomide 6 Specimen Handling 6 Filgrastim 6 tazemetostat 5 fludarabine 5 Vincristine 5 Topotecan 5 Stem Cell Transplantation 5 Radiotherapy 5 Nuclear Medicine Department, Hospital 5 Methotrexate 5 Cisplatin 5 Melphalan 4 Biopsy 4 palbociclib 3 fludarabine phosphate 3 Sirolimus 3 Peripheral Blood Stem Cell Transplantation 3 Mesna 3 Ifosfamide 3 Busulfan 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02114229 2026-03-17

SJATRT

St. Jude Children's Research Hospital

Phase 2 Active not recruiting

Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡